RxDoctor Payments Data

Andrew Bernard, MD

Surgical Critical Care · Lexington, KYNPI 1326097049

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Davol Inc. at 56.6% of the total. Reporting peaked in 2022 at $887 and has fallen 83.1% since, to $150 in 2025.

$1,219in general payments, 2019–2025

Across 13 payments — averaging $93.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Davol Inc.$690
  • Atricure, Inc.$164
  • Johnson & Johnson$113
  • Solventum Corporation$111
  • BD$69
  • CLR Medical, Inc.$55
  • plus $16 from 1 others
$1,905in research payments, 2019–2025

Across 1 payment — averaging $1905.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ferring International Pharmascience Center US$2K

What the payments were for

  • Food & beverage$1,219100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Davol Inc.6$690
Atricure, Inc.2$164
Johnson & Johnson1$113
Solventum Corporation1$111
BD1$69
CLR Medical, Inc.1$55
Jazz Pharmaceuticals Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,219 in reported general payments places this provider in the 60th percentile of 31 surgical critical care providers in Kentucky.

See all surgical critical care providers in Kentucky

Medicare billing

Part B allowed, 2024
$72,211
Medicare patients
258
Services billed
529

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl74$2,581
Codeine Sulfate13$587
Gabapentin13$95
Methocarbamol14$77

Paid to pharmacies, not to this prescriber.

Other surgical critical care in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →